Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
株式のランク #23
Johnson & Johnson is a holding company, which engages in the research,... Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
株価
$267.84
時価総額
$645.47B
変化(1日)
-0.63%
変化(1年)
51.68%
US
取引 Johnson & Johnson (JNJ)

カテゴリー

Johnson & Johnson(JNJ)の収益
Jun 2026 時点の収益 TTM: $97.93B
Johnson & Johnson の最新の財務報告によると、現在の収益 (TTM) は $97.93B です。2024 年には $88.82B の収益があり、これは 2023 年の $85.16B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Johnson & Johnson の収益履歴(2000 ~ 2026)
各年末の収益
収益 変化
2026 (TTM) $97.93B 3.97%
2025 $94.19B 6.05%
2024 $88.82B 4.30%
2023 $85.16B 8.15%
2022 $78.74B -4.65%
2021 $82.58B 0.64%
2019 $82.06B 0.59%
2018 $81.58B 6.71%
2017 $76.45B 6.34%
2016 $71.89B 2.59%
2015 $70.07B -5.73%
2014 $74.33B 4.23%
2013 $71.31B 6.08%
2012 $67.22B 3.37%
2011 $65.03B 5.59%
2010 $61.59B -0.50%
2009 $61.90B -2.90%
2008 $63.75B 4.34%
2007 $61.10B 14.57%
2006 $53.32B 5.56%
2005 $50.51B 6.69%
2004 $47.35B 13.10%
2003 $41.86B 15.33%
2002 $36.30B 12.32%
2001 $32.32B 10.78%
2000 $29.17B 0.00%
同業他社の収益
企業 収益 収益の差
$79.67B -18.65%
US
$64.39B -34.25%
US
$77.52B -20.84%
CH
$66.40B -32.20%
US
$56.26B -42.55%
CH